StimLabs develops and manufactures regenerative medical products for surgical and wound care applications, specializing in placental allografts and tissue barriers for surgical procedures.

StimLabs

StimLabs | 4,965 followers on LinkedIn. StimLabs was founded in 2015 with a desire to advance the state of regenerative medicine. In pursuit of this goal, StimLabs has gathered exceptional scientific and clinical minds to develop and commercialize new bioactive technologies. Within a year of its inception, StimLabs conceptualized and launched a suite of amniotic-derived products, developed an extensive product pipeline across a range of clinical applications, and established a portfolio of intellectual property.

Rob Frohwein

Facility Manager for regulated industry

David Massie

Vice President, Market Access

Owen Reilly

Biologic and Medical Device Sales

Tyler Webb, MBA

StimLabs is attending the 72nd Annual Detroit Trauma Symposium at MGM Grand Detroit! Stop by our booth to learn more about the use of Dehydrated Complete Human Placental Membrane (dCHPM) Allografts. #stimlabs #traumasurgery

Follow this fascinating case detailing the use of Cogenex in a lower eyelid Mohs defect. https://bit.ly/4hlvInc Cogenex, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft, acts as a selective barrier offering protection to wounds from their surrounding environment while allowing wound exudate to drain. Katie Sikora Viscusi, MD Dermatology and Surgery Specialists of North Atlanta #Stimlabs #Cogenex #Mohs

Corplex P is the ONLY FDA-cleared medical device derived from human birth tissue and intended for wound management. Interested in how Corplex P addresses these wound types? Visit https://bit.ly/4fpMpMJ to learn more. #stimlabs #corplexp

We always value the moments when the StimLabs team comes together, both in-person and virtually. At this Town Hall Meeting, we shared important updates, celebrated our achievements, discussed future goals, and enjoyed some well-deserved indulgence and fun! #stimlabs

Learn more about all of the advantages of Corplex P. https://bit.ly/3YpJLkq #CorplexP #StimLabs #UmbilicalCord

StimLabs just attended the largest American Association of Tissue Banks Annual Meeting to date, bringing together over 1,000 attendees, including more than 250 first-timers! A special shoutout to our team members, John Daniel , Melissa O'Connor, FRAPS, MS, RAC-US, CTBS , Jonathan Cisneros , Jennifer Roe- MBA , Allison Rickman , Brooke Whipple , and Dana M. McCullough who made an impact at the conference: Melissa O'Connor, an AATB board member, engaged in multiple panel discussions, including the critical role of tissue banks in interfacing with Congress and navigating regulatory inspections. Jonathan Cisneros shared insights during a panel discussion on the differences between vaginal and C-section birth tissue donation. Mark your calendars for next year in our hometown, Atlanta! #stimlabs #AATB #AATBAnnualMeeting

That was another outstanding Symposium on Advanced Wound Care (SAWC)! It was a pleasure to participate in a conference designed for healthcare professionals to elevate wound care. Let's stay connected at https://bit.ly/3ZZF162 #SAWCFall #SAWCFall2024 #woundcare #StimLabs

𝗥𝗲𝗺𝗼𝗱𝗲𝗹𝗶𝗻𝗴 𝗪𝗼𝘂𝗻𝗱 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗗𝗿. 𝗝𝗮𝗺𝗶𝘀𝗼𝗻 𝗙𝗲𝗿𝗮𝗺𝗶𝘀𝗰𝗼, 𝗠𝗗, 𝗣𝗵𝗗 Don’t miss Dr. Feramisco’s discussion about Corplex P, the first and only FDA cleared human birth tissue-derived medical device for wound management. #SAWCFall2024 #Stimlabs #CorplexP

Come see our poster, A Novel Dehydrated Human Umbilical Cord Particulate (dHUCP) Medical Device: Matrix Characterization & Performance for the Management of Acute and Chronic Wounds at the #SAWCFall poster hall. #stimlabs #umbilicalcord #allograft

Join this CME/CPME/CE-Accredited hands-on workshop to learn how innovative technologies like dCHPM and dHUCP can play a role in your treatment and management of lower extremity wounds. #SAWCFall2024 #Stimlabs

STIM

COM:STIMLABS

StimLabs

locale

market

industry

website

crunchbase

linkedin

competitor of

Metrics